Safety, Tolerability, and Clinical Effects of Twice-daily Doses of Cinacalcet (AMG 073) in Adults With Primary Hyperparathyroidism (HPT)

Clinical trial NCT03776058 · COMPLETED

Trial details

NCT number: NCT03776058
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Hyperparathyroidism

Start date: 2000-06-15
Primary completion: 2000-12-26
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.